Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2007
Business Overview: The Company operates in two primary segments: Oral, Personal and Home Care (divided into North America, Latin America, Europe/South Pacific, and Greater Asia/Africa) and Pet Nutrition (Hill's Pet Nutrition). The Company is executing a four-year restructuring program (2004 Restructuring Program) aimed at enhancing global leadership and reducing costs.
Key Financial Metrics
| Metric (in millions, except per share) | Three Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2007 |
|---|---|---|
| Net Sales | $3,528.2 | $10,147.5 |
| Gross Profit | $1,983.6 | $5,704.2 |
| Gross Margin | 56.2% | 56.2% |
| Operating Profit | $668.8 | $1,977.5 |
| Net Income | $420.1 | $1,322.5 |
| Diluted EPS | $0.77 | $2.43 |
| Operating Cash Flow (9mo) | $1,638.7 | |
| Cash and Equivalents (Sep 30, 2007) | $628.4 | |
| Total Debt (Current + Long-term) | $3,608.2 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 12.0% in Q3 2007 and 12.5% for the nine-month period compared to 2006. Growth was driven by volume increases (5.5% in Q3, 7.0% YTD), net selling price increases, and favorable foreign exchange impacts.
- Profitability: Operating profit rose 22% in Q3 and 29% YTD. This improvement was primarily due to lower restructuring charges ($51.1M in Q3 2007 vs. $84.0M in Q3 2006) and a $48.6M pretax gain from the sale of Latin American household bleach businesses.
- Net Income: Net income increased 22% in Q3 and 39% YTD. The YTD increase included a $73.9M tax benefit from the reduction of a valuation allowance on tax loss carryforwards in Brazil.
- Segment Performance: All geographic regions reported sales growth. Latin America saw the highest volume growth (7.5% in Q3), while Greater Asia/Africa reported the highest operating profit growth (38%).
Guidance, Outlook, and Risks
- Restructuring Program: The 2004 Restructuring Program was expanded in April 2007. Cumulative pretax charges are now estimated between $925M and $1,075M. The program is expected to generate annual savings of $400M to $475M by 2008.
- Capital Allocation: The Company increased the annualized common stock dividend by 13% to $1.44 per share. It also repurchased $866.6M of treasury shares in the first nine months of 2007.
- Legal and Tax Contingencies:
- Brazil: The Company is disputing tax assessments totaling approximately $120M related to the Kolynos acquisition financing. A $140M fine imposed by the Central Bank of Brazil was dismissed on appeal in January 2007.
- Mexico: Tax authorities issued assessments totaling approximately $795M (VAT and income tax) which the Company intends to challenge vigorously.
- Competition Law: Investigations are ongoing in France, Switzerland, Romania, and Germany regarding potential competition law violations. No fines have been assessed to date.
- Pet Food Recall: Hill's Pet Nutrition conducted a voluntary recall in Q1 2007 due to melamine contamination. The impact on annual sales is estimated at 0.5% of Hill's sales, with costs recorded in the Corporate segment.
- Outlook: Management expects market conditions to remain competitive but believes the Company is well-positioned for continued growth due to its global brand strength and capital base.
Investor Verification Checklist
- Restructuring Costs: Verify the remaining cash outflows associated with the expanded 2004 Restructuring Program and the timeline for completion (Dec 31, 2008).
- Tax Contingencies: Monitor the status of the Brazilian and Mexican tax disputes, as potential liabilities could impact future earnings if not resolved favorably.
- Foreign Exchange Sensitivity: Assess the impact of currency fluctuations on reported sales and earnings, given the significant positive FX impact in the current period.
- Competition Law Exposure: Track the outcome of antitrust investigations in Europe to determine potential fines or operational changes.
- Divestiture Proceeds: Confirm the finalization of the bleach brand sales, particularly the regulatory status in Colombia.